Edmond DE Rothschild Holding S.A. decreased its holdings in Colgate-Palmolive (NYSE:CL – Free Report) by 7.2% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 45,931 shares of the company’s stock after selling 3,573 shares during the quarter. Edmond DE Rothschild Holding S.A.’s holdings in Colgate-Palmolive were worth $4,176,000 as of its most recent filing with the SEC.
A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Kohmann Bosshard Financial Services LLC purchased a new stake in shares of Colgate-Palmolive in the fourth quarter worth approximately $26,000. Centricity Wealth Management LLC acquired a new position in shares of Colgate-Palmolive during the 4th quarter valued at about $27,000. Union Bancaire Privee UBP SA bought a new position in shares of Colgate-Palmolive in the fourth quarter valued at approximately $32,000. Briaud Financial Planning Inc bought a new position in Colgate-Palmolive in the 4th quarter worth $32,000. Finally, Wintrust Investments LLC acquired a new position in shares of Colgate-Palmolive during the 4th quarter worth about $33,000. Institutional investors own 80.41% of the company’s stock.
Wall Street Analyst Weigh In
A number of brokerages have commented on CL. TD Cowen reduced their price objective on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research report on Wednesday, January 8th. Barclays lifted their price objective on Colgate-Palmolive from $83.00 to $89.00 and gave the company an “equal weight” rating in a research report on Thursday, March 27th. Royal Bank of Canada reiterated a “sector perform” rating and set a $101.00 target price on shares of Colgate-Palmolive in a research report on Wednesday, January 29th. Piper Sandler decreased their price target on Colgate-Palmolive from $108.00 to $107.00 and set an “overweight” rating on the stock in a report on Monday. Finally, UBS Group lowered their target price on shares of Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating for the company in a report on Monday, February 3rd. One analyst has rated the stock with a sell rating, ten have assigned a hold rating and eleven have issued a buy rating to the company. Based on data from MarketBeat, Colgate-Palmolive presently has a consensus rating of “Hold” and a consensus price target of $101.78.
Colgate-Palmolive Stock Up 1.1 %
Shares of NYSE:CL opened at $93.84 on Tuesday. The company has a market cap of $76.11 billion, a PE ratio of 26.66, a P/E/G ratio of 4.20 and a beta of 0.40. Colgate-Palmolive has a 1 year low of $85.32 and a 1 year high of $109.30. The stock’s 50-day moving average is $89.80 and its 200 day moving average is $93.44. The company has a debt-to-equity ratio of 13.40, a current ratio of 0.92 and a quick ratio of 0.58.
Colgate-Palmolive (NYSE:CL – Get Free Report) last issued its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period in the previous year, the business earned $0.87 EPS. Sell-side analysts anticipate that Colgate-Palmolive will post 3.75 EPS for the current year.
Colgate-Palmolive Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Thursday, May 15th. Shareholders of record on Thursday, April 17th will be given a $0.52 dividend. This represents a $2.08 dividend on an annualized basis and a yield of 2.22%. The ex-dividend date is Thursday, April 17th. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.50. Colgate-Palmolive’s payout ratio is 59.09%.
Colgate-Palmolive announced that its board has approved a stock repurchase program on Thursday, March 20th that authorizes the company to repurchase $5.00 billion in shares. This repurchase authorization authorizes the company to repurchase up to 6.8% of its stock through open market purchases. Stock repurchase programs are often a sign that the company’s board of directors believes its stock is undervalued.
Colgate-Palmolive Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Articles
- Five stocks we like better than Colgate-Palmolive
- 3 Grocery Stocks That Are Proving They Are Still Essential
- 3 Buyable Stocks With Solid Bottoms Ready to Rebound
- What Is WallStreetBets and What Stocks Are They Targeting?
- Advantage+ Shopping: Meta’s Fast Growing $20 Billion AI-Ads Star
- 10 Best Airline Stocks to Buy
- Robotaxi News: What Tesla and Lyft Headlines Mean for Shares
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.